LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: 11C-methionine PET/MRI in postoperative patients after craniotomy: zero echo time and head atlas versus CT-based attenuation correction.

    DE Luca, Francesca / Bolin, Martin / Blomqvist, Lennart / Wassberg, Cecilia / Martin, Heather / Falk Delgado, Anna

    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

    2022  Volume 67, Issue 3, Page(s) 215–222

    Abstract: Background: Attenuation correction (AC) is an important topic in PET/MRI and particularly challenging after brain tumor surgery, near metal implants, adjacent bone and burr holes. In this study, we evaluated the performance of two MR-driven AC methods, ... ...

    Abstract Background: Attenuation correction (AC) is an important topic in PET/MRI and particularly challenging after brain tumor surgery, near metal implants, adjacent bone and burr holes. In this study, we evaluated the performance of two MR-driven AC methods, zero-echo-time AC (ZTE-AC) and atlas-AC, in comparison to reference standard CT-AC in patients with surgically treated brain tumors at
    Methods: This retrospective study investigated seven postoperative patients with neuropathologically confirmed brain tumor at
    Results: Smaller mean percent bias range (Bland-Altman) was found for ZTE-AC than atlas-AC in all analyses (metal ZTE -0.46 to -0.02, metal atlas -3.57 to -3.26; bone ZTE -4.60 to -2.16, bone atlas -5.25 to -3.81; burr hole ZTE -0.95 to -0.52, burr hole atlas 7.86 to 8.87). Percent SD range (Bland-Altman) was large for both methods in all analyses, with lower absolute values for ZTE-AC (ZTE 7.02-8.49; atlas 11.47-14.83). A very strong correlation (Pearson correlation) was demonstrated for both methods compared to CT-AC (ZTE ρ 0.97-0.99, P<0.001; atlas ρ 0.88-0.91, P≤0.009) with higher absolute values for ZTE. An excellent intraclass correlation coefficient was found across all analyses for ZTE, atlas and CT maps (ICC ≥0.88).
    Conclusions: ZTE for MR-driven PET attenuation correction presented a more comparable performance to reference standard CT-AC at the postoperative site. ZTE-AC may serve as a useful diagnostic tool for MR-driven AC in patients with surgically treated brain tumors.
    MeSH term(s) Humans ; Carbon Radioisotopes ; Multimodal Imaging/methods ; Retrospective Studies ; Reproducibility of Results ; Brain/diagnostic imaging ; Fluorodeoxyglucose F18 ; Positron-Emission Tomography/methods ; Magnetic Resonance Imaging/methods ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/surgery ; Brain Neoplasms/pathology ; Methionine ; Craniotomy ; Racemethionine ; Tomography, X-Ray Computed/methods ; Image Processing, Computer-Assisted/methods
    Chemical Substances Carbon-11 ; Carbon Radioisotopes ; Fluorodeoxyglucose F18 (0Z5B2CJX4D) ; carbon-11 methionine (58576-49-1) ; Methionine (AE28F7PNPL) ; Racemethionine (73JWT2K6T3)
    Language English
    Publishing date 2022-02-04
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 1281687-5
    ISSN 1827-1936 ; 0392-0208 ; 1125-0135 ; 1824-4661 ; 1824-4785
    ISSN (online) 1827-1936
    ISSN 0392-0208 ; 1125-0135 ; 1824-4661 ; 1824-4785
    DOI 10.23736/S1824-4785.22.03389-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol.

    Svensson, Jonas E / Bolin, Martin / Thor, Daniel / Williams, Pete A / Brautaset, Rune / Carlsson, Marcus / Sörensson, Peder / Marlevi, David / Spin-Neto, Rubens / Probst, Monika / Hagman, Göran / Morén, Anton Forsberg / Kivipelto, Miia / Plavén-Sigray, Pontus

    BMC neurology

    2024  Volume 24, Issue 1, Page(s) 111

    Abstract: Background: Rapamycin is an inhibitor of the mechanistic target of rapamycin (mTOR) protein kinase, and preclinical data demonstrate that it is a promising candidate for a general gero- and neuroprotective treatment in humans. Results from mouse models ... ...

    Abstract Background: Rapamycin is an inhibitor of the mechanistic target of rapamycin (mTOR) protein kinase, and preclinical data demonstrate that it is a promising candidate for a general gero- and neuroprotective treatment in humans. Results from mouse models of Alzheimer's disease have shown beneficial effects of rapamycin, including preventing or reversing cognitive deficits, reducing amyloid oligomers and tauopathies and normalizing synaptic plasticity and cerebral glucose uptake. The "Evaluating Rapamycin Treatment in Alzheimer's Disease using Positron Emission Tomography" (ERAP) trial aims to test if these results translate to humans through evaluating the change in cerebral glucose uptake following six months of rapamycin treatment in participants with early-stage Alzheimer's disease.
    Methods: ERAP is a six-month-long, single-arm, open-label, phase IIa biomarker-driven study evaluating if the drug rapamycin can be repurposed to treat Alzheimer's disease. Fifteen patients will be included and treated with a weekly dose of 7 mg rapamycin for six months. The primary endpoint will be change in cerebral glucose uptake, measured using [
    Discussion: The ERAP study is a clinical trial using in vivo imaging biomarkers to assess the repurposing of rapamycin for the treatment of Alzheimer's disease. If successful, the study would provide a strong rationale for large-scale evaluation of mTOR-inhibitors as a potential disease-modifying treatment in Alzheimer's disease.
    Trial registration: ClinicalTrials.gov ID NCT06022068, date of registration 2023-08-30.
    MeSH term(s) Animals ; Mice ; Humans ; Alzheimer Disease/diagnostic imaging ; Alzheimer Disease/drug therapy ; Alzheimer Disease/complications ; Aging ; Cognition Disorders ; Positron-Emission Tomography/methods ; Glucose/metabolism ; TOR Serine-Threonine Kinases ; Amyloid beta-Peptides/cerebrospinal fluid ; Clinical Trials, Phase II as Topic
    Chemical Substances Glucose (IY9XDZ35W2) ; TOR Serine-Threonine Kinases (EC 2.7.11.1) ; Amyloid beta-Peptides
    Language English
    Publishing date 2024-04-04
    Publishing country England
    Document type Clinical Trial Protocol ; Journal Article
    ZDB-ID 2041347-6
    ISSN 1471-2377 ; 1471-2377
    ISSN (online) 1471-2377
    ISSN 1471-2377
    DOI 10.1186/s12883-024-03596-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Development of a Novel [

    Nag, Sangram / Bolin, Martin / Datta, Prodip / Arakawa, Ryosuke / Forsberg Morén, Anton / Khani Maynaq, Yasir / Lin, Edward / Genung, Nathan / Hering, Heike / Guckian, Kevin / Martarello, Laurent / Kaliszczak, Maciej / Halldin, Christer

    ACS chemical neuroscience

    2023  Volume 14, Issue 14, Page(s) 2560–2568

    Abstract: ... ...

    Abstract Imaging
    MeSH term(s) Animals ; Macaca fascicularis/metabolism ; Positron-Emission Tomography/methods ; Carbon Radioisotopes/metabolism ; Brain/diagnostic imaging ; Brain/metabolism ; Radiopharmaceuticals/metabolism
    Chemical Substances Carbon-11 ; hexosaminidase C (EC 3.2.1.50) ; Carbon Radioisotopes ; Radiopharmaceuticals
    Language English
    Publishing date 2023-06-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1948-7193
    ISSN (online) 1948-7193
    DOI 10.1021/acschemneuro.3c00247
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Validation of PET/MRI attenuation correction methodology in the study of brain tumours.

    De Luca, Francesca / Bolin, Martin / Blomqvist, Lennart / Wassberg, Cecilia / Martin, Heather / Falk Delgado, Anna

    BMC medical imaging

    2020  Volume 20, Issue 1, Page(s) 126

    Abstract: Background: This study aims to compare proton density weighted magnetic resonance imaging (MRI) zero echo time (ZTE) and head atlas attenuation correction (AC) to the reference standard computed tomography (CT) based AC for : Methods: A retrospective ...

    Abstract Background: This study aims to compare proton density weighted magnetic resonance imaging (MRI) zero echo time (ZTE) and head atlas attenuation correction (AC) to the reference standard computed tomography (CT) based AC for
    Methods: A retrospective cohort of 14 patients with suspected or confirmed brain tumour and
    Results: ZTE-AC demonstrated narrower SD and 95% CI (Bland-Altman) than atlas-AC in the hotspot analysis for all groups (ZTE overall ≤ 2.84, - 1.41 to 1.70; metal ≤ 1.67, - 3.00 to 2.20; non-metal ≤ 3.04, - 0.96 to 3.38; Atlas overall ≤ 4.56, - 1.05 to 3.83; metal ≤ 3.87, - 3.81 to 4.64; non-metal ≤ 4.90, - 1.68 to 5.86). The mean bias for both ZTE-AC and atlas-AC was ≤ 2.4% compared to CT-AC. In the metal region analysis, ZTE-AC demonstrated a narrower mean bias range-closer to zero-and narrower SD and 95% CI (ZTE 0.21-0.48, ≤ 2.50, - 1.70 to 2.57; Atlas 0.56-1.54, ≤ 4.01, - 1.81 to 4.89). The mean bias for both ZTE-AC and atlas-AC was within 1.6%. A perfect correlation (Pearson correlation) was found for both ZTE-AC and atlas-AC compared to CT-AC in the hotspot and metal analysis (ZTE ρ 1.00, p < 0.0001; atlas ρ 1.00, p < 0.0001). An almost perfect intraclass correlation coefficient for absolute agreement was found between Atlas-, ZTE and CT maps for maxSUR and meanSUR values in all the analyses (ICC > 0.99).
    Conclusions: Both ZTE and atlas-AC showed a good performance against CT-AC in patients with brain tumour.
    MeSH term(s) Adult ; Aged ; Atlases as Topic ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/pathology ; Brain Neoplasms/surgery ; Carbon Radioisotopes ; Female ; Humans ; Image Processing, Computer-Assisted ; Male ; Methionine ; Middle Aged ; Neuroimaging ; Positron Emission Tomography Computed Tomography ; Reference Standards ; Retrospective Studies
    Chemical Substances Carbon Radioisotopes ; Methionine (AE28F7PNPL)
    Language English
    Publishing date 2020-11-25
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Validation Study
    ZDB-ID 2061975-3
    ISSN 1471-2342 ; 1471-2342
    ISSN (online) 1471-2342
    ISSN 1471-2342
    DOI 10.1186/s12880-020-00526-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Development of a PET Tracer for OGA with Improved Kinetics in the Living Brain.

    Cook, Brendon E / Nag, Sangram / Arakawa, Ryosuke / Lin, Edward Yin-Shiang / Stratman, Nancy / Guckian, Kevin / Hering, Heike / Lulla, Mukesh / Choi, Jinkuk / Salinas, Cristian / Genung, Nathan E / Morén, Anton Forsberg / Bolin, Martin / Boscutti, Giulia / Plisson, Christophe / Martarello, Laurent / Halldin, Christer / Kaliszczak, Maciej A

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    2023  Volume 64, Issue 10, Page(s) 1588–1593

    Abstract: ... ...

    Abstract O
    MeSH term(s) Humans ; Rats ; Animals ; beta-N-Acetylhexosaminidases ; Brain ; Pyrans
    Chemical Substances hexosaminidase C (EC 3.2.1.50) ; thiamet G ; beta-N-Acetylhexosaminidases (EC 3.2.1.52) ; Pyrans
    Language English
    Publishing date 2023-07-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80272-4
    ISSN 1535-5667 ; 0097-9058 ; 0161-5505 ; 0022-3123
    ISSN (online) 1535-5667
    ISSN 0097-9058 ; 0161-5505 ; 0022-3123
    DOI 10.2967/jnumed.122.265225
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [

    Arakawa, Ryosuke / Takano, Akihiro / Stenkrona, Per / Stepanov, Vladimir / Nag, Sangram / Jahan, Mahabuba / Grybäck, Per / Bolin, Martin / Chen, Laigao / Zhang, Lei / He, Ping / Villalobos, Anabella / McCarthy, Timothy J / Halldin, Christer / Varrone, Andrea

    European journal of nuclear medicine and molecular imaging

    2020  Volume 47, Issue 10, Page(s) 2429–2439

    Abstract: Purpose: Beta-secretase 1 (BACE1) enzyme is implicated in the pathophysiology of Alzheimer's disease. [: Methods: Five subjects were studied for the dosimetry study. Whole-body PET was performed for 366 min with 4 PET-CT sessions. Estimates of the ... ...

    Abstract Purpose: Beta-secretase 1 (BACE1) enzyme is implicated in the pathophysiology of Alzheimer's disease. [
    Methods: Five subjects were studied for the dosimetry study. Whole-body PET was performed for 366 min with 4 PET-CT sessions. Estimates of the absorbed radiation dose were calculated using the male adult model. Eight subjects participated in the test-retest study. Brain PET measurements were conducted for 123 min with an interval of 5 to 19 days between test and retest conditions. The total distribution volume (V
    Results: In the dosimetry study, the highest uptake was found in the liver (25.2 ± 2.3 %ID at 0.5 h) and the largest dose was observed in the pancreas (92.9 ± 52.2 μSv/MBq). The calculated ED was 24.7 ± 0.8 μSv/MBq. In the test-retest study, 2TCM described the time-activity curves well. V
    Conclusion: The ED of [
    Trial registration: EudraCT 2016-001110-19 (registered 2016-08-08).
    MeSH term(s) Adult ; Amyloid Precursor Protein Secretases ; Aspartic Acid Endopeptidases ; Brain/diagnostic imaging ; Humans ; Male ; Positron Emission Tomography Computed Tomography ; Positron-Emission Tomography ; Radiometry ; Radiopharmaceuticals ; Reproducibility of Results ; Tissue Distribution ; Tomography, X-Ray Computed
    Chemical Substances Radiopharmaceuticals ; Amyloid Precursor Protein Secretases (EC 3.4.-) ; Aspartic Acid Endopeptidases (EC 3.4.23.-)
    Language English
    Publishing date 2020-03-06
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 8236-3
    ISSN 1619-7089 ; 0340-6997 ; 1619-7070
    ISSN (online) 1619-7089
    ISSN 0340-6997 ; 1619-7070
    DOI 10.1007/s00259-020-04739-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Quantification and reliability of [

    Cselényi, Zsolt / Jucaite, Aurelija / Kristensson, Cecilia / Stenkrona, Per / Ewing, Pär / Varrone, Andrea / Johnström, Peter / Schou, Magnus / Vazquez-Romero, Ana / Moein, Mohammad Mahdi / Bolin, Martin / Siikanen, Jonathan / Grybäck, Pär / Larsson, Bengt / Halldin, Christer / Grime, Ken / Eriksson, Ulf G / Farde, Lars

    EJNMMI research

    2020  Volume 10, Issue 1, Page(s) 59

    Abstract: Background: The radioligand [: Methods: PET measurements using [: Results: The 1TCM was the statistically preferred model for description of [: Conclusions: The kinetic behaviour and good repeatability of [: Trial registration: ... ...

    Abstract Background: The radioligand [
    Methods: PET measurements using [
    Results: The 1TCM was the statistically preferred model for description of [
    Conclusions: The kinetic behaviour and good repeatability of [
    Trial registration: ClinicalTrials.gov identifier: NCT03097380, registered: 31 March 2017.
    Language English
    Publishing date 2020-06-03
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2619892-7
    ISSN 2191-219X
    ISSN 2191-219X
    DOI 10.1186/s13550-020-00634-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top